Abstract
Flora Tang started biotech consulting on drug discovery operation and technology in 2007. Flora has extensive pharmaceutical experiences working at Amgen as Director of Research; SUGEN (subsidiary of Pharmacia) as Director of Discovery Technology; Eli Lilly; and GlaxoSmithKline. The scope of her work experiences involves high throughput biology using cutting-edge technologies and managing business operations. Flora started applying high content screening to drug discovery process soon after the inception of HCS.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Combinatorial Chemistry & High Throughput Screening
Paper Title
Journal
Date
